Cargando…

Prognostic Impact of let-7e MicroRNA and Its Target Genes in Localized High-Risk Intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study

SIMPLE SUMMARY: For intestinal localized high-risk gastrointestinal stromal tumors (GIST) patients’ new molecular biomarkers are urgently needed for a more accurate prognosis. In our study, miRNA profiling analyses was planned to explore new molecular biomarkers with potential prognostic role in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez-Serra, Antonio, Moura, David S., Sanchez-Izquierdo, María Dolores, Calabuig-Fariñas, Silvia, Lopez-Alvarez, Maria, Martínez-Martínez, Andrea, Carrasco-Garcia, Irene, Ramírez-Calvo, Marta, Blanco-Alcaina, Elena, López-Reig, Raquel, Obrador-Hevia, Antonia, Alemany, Regina, Gutierrez, Antonio, Hindi, Nadia, Poveda, Andres, Lopez-Guerrero, Jose A., Martin-Broto, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602387/ https://www.ncbi.nlm.nih.gov/pubmed/33066614 http://dx.doi.org/10.3390/cancers12102979

Ejemplares similares

GEIS 2013 guidelines for gastrointestinal sarcomas (GIST)
por: Poveda, Andrés, et al.
Publicado: (2014)

CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study
por: Moura, David S., et al.
Publicado: (2020)

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
por: Martin-Broto, Javier, et al.
Publicado: (2023)

2023 GEIS Guidelines for gastrointestinal stromal tumors
por: Serrano, César, et al.
Publicado: (2023)

Cancer Stem Cells in Soft-Tissue Sarcomas
por: Martínez-Delgado, Paula, et al.
Publicado: (2020)

Phosphorylated-insulin growth factor I receptor (p-IGF1R) and metalloproteinase-3 (MMP3) expression in advanced gastrointestinal stromal tumors (GIST). A GEIS 19 study
por: Maurel, Joan, et al.
Publicado: (2016)

SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)
por: Serrano, César, et al.
Publicado: (2023)

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)
por: Redondo, Andrés, et al.
Publicado: (2017)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
por: Martínez-Trufero, Javier, et al.
Publicado: (2021)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)
por: Mora, J, et al.
Publicado: (2017)

Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019)

Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
por: Garcia del Muro, Xavier, et al.
Publicado: (2015)

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2023)

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients
por: Moura, David S., et al.
Publicado: (2018)

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Martinez-Font, Esther, et al.
Publicado: (2021)

Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS)
por: Pérez-Fidalgo, Jose Alejandro, et al.
Publicado: (2023)

SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)
por: Poveda, A., et al.
Publicado: (2016)

Nilotinib Counteracts P-Glycoprotein-Mediated Multidrug Resistance and Synergizes the Antitumoral Effect of Doxorubicin in Soft Tissue Sarcomas
por: Villar, Victor Hugo, et al.
Publicado: (2012)

Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
por: López-Pousa, A, et al.
Publicado: (2006)

Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas
por: Martinez-Font, Esther, et al.
Publicado: (2020)

Capacity-building efforts by the AFHSC-GEIS program
por: Sanchez, Jose L, et al.
Publicado: (2011)

Antimicrobial resistance surveillance in the AFHSC-GEIS network
por: Meyer, William G, et al.
Publicado: (2011)

Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas
por: López-Álvarez, María, et al.
Publicado: (2022)

Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study
por: Jongsma, Hannah E., et al.
Publicado: (2017)

Phase II Trial of Doxorubicin Plus Escalated High-Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS)
por: López-Pousa, A., et al.
Publicado: (2006)

Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS)
por: Poveda, A., et al.
Publicado: (2005)

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
por: Poveda, Andres, et al.
Publicado: (2021)

Spanish menstrual literacy and experiences of menstruation
por: Sánchez López, Sara, et al.
Publicado: (2023)

Specificity of Stenurus (Metastrongyloidea: Pseudaliidae) infections in odontocetes stranded along the north-west Spanish coast
por: Saldaña, A., et al.
Publicado: (2022)

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
por: Martin-Broto, Javier, et al.
Publicado: (2020)

Platinum-Based Regimens Are Active in Advanced Pediatric-Type Rhabdomyosarcoma in Adults and Depending on HMGB1 Expression
por: Hindi, Nadia, et al.
Publicado: (2023)

Migration history and risk of psychosis: results from the multinational EU-GEI study
por: Tarricone, Ilaria, et al.
Publicado: (2022)

ISG15 as a prognostic biomarker in solitary fibrous tumour
por: Mondaza-Hernandez, Jose L., et al.
Publicado: (2022)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
por: Mondelo-Macía, Patricia, et al.
Publicado: (2020)

A GIST or not a GIST? That is the question
por: Chrysanthos, Nikolaos, et al.
Publicado: (2014)

Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
por: Martin-Broto, Javier, et al.
Publicado: (2023)

Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR
por: Esteva-Socias, Margalida, et al.
Publicado: (2020)

Data on green Spanish-style Manzanilla table olives fermented in salt mixtures
por: López-López, Antonio, et al.
Publicado: (2016)

Let there be more light!
por: López-Gil, Norberto
Publicado: (2016)

GIST in a reference cancer center in México
por: López-Basave, Horacio Noe, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jtr3ts3fa8vjggmcl9j8k72g8s